THE INSTITUTE FOR CANCER VACCINES AND IMMUNOTHERAPY

Registered charity 1080343 · accounts filings on the Charity Commission register · also known as CVI, THE CANCER VACCINE INSTITUTE LIMITED

The principal activity of the charity is the advancement of education and the protection and preservation of public health by promoting research into the treatment of cancer by vaccine technology and by promoting the dissemination of the useful results of such research.

Objects

THE ADVANCEMENT OF EDUCATION AND THE PROTECTION AND PRESERVATION OF PUBLIC HEALTH BY PROMOTING RESEARCH INTO THE TREATMENT OF CANCER BY VACCINE TECHNOLOGY, AND BY PROMOTING THE DISSEMINATION OF THE USEFUL RESULTS OF SUCH RESEARCH.

Area of benefit: NOT DEFINED

The charity’s charitable objects and area of benefit, quoted from its governing document as held on the Charity Commission register.

Causes: Education/training · The Advancement Of Health Or Saving Of Lives · Grant history (this charity is a funder) · website · Get email alerts

Registered contact address: Wandsworth, London, England (from the postcode on the register)

Latest income
£433k
Latest spending
£547k
Registered
2000
Accounts read
FY2025

Financial health, per its FY2025 accounts

The accounts state that the charity reported a net deficit of £122,083 for the year ended 31 March 2025, resulting in a decrease in total net assets to £993,795. Per the trustees' report, unrestricted reserves stood at £852,749, which the trustees consider sufficient to cover committed operating costs and provide flexibility for temporary shortfalls in fundraising revenues. The charity maintains its reserves in cash or cash equivalents to maintain short-term capital value amid market uncertainties.

Automated summary of the FY2025 accounts; the evidenced findings below carry the verbatim passages.

What the accounts disclose

Highest-paid employee band: £70,001 - £80,000 — above the 90th percentile for charities its size (median £60k)
“One employee received remuneration of £70,000 or greater in the band £70,000 - £80,000.” — page 27
Per its FY2025 accounts as filed with the Charity Commission.
Employees paid over £60,000: 1
“One employee received remuneration of £70,000 or greater in the band £70,000 - £80,000.” — page 27
Per its FY2025 accounts as filed with the Charity Commission.
Largest income source: Charitable Trusts/Corporate Donations (42% of income)
“Charitable Trusts/Corporate Donations £157,206”
Per its FY2025 accounts as filed with the Charity Commission.
Fundraising cost ratio: 6.0% of fundraised income, as disclosed
“direct fundraising costs were 6% (2024 6%), with management, support and governance the remaining 18% (2024 15%).”
Per its FY2025 accounts as filed with the Charity Commission.

Accounts audited by Bryden Johnson Limited. Discloses 5 of 6 completeness components.

Policies the charity declares

In its annual return the charity told the Commission that it has the policies listed below. This is self-declared: it is not verified by the Commission or by this site, and it is not evidence of how a policy works in practice.

From the charity’s annual return (Part A, self-declared)

Answers and figures the charity gave in Part A of its annual return to the Charity Commission. They are self-declared: not verified by the Commission or by this site. Only positive answers and figures are listed; items not listed are simply not shown.

Self-declared on the annual return for the financial year ending 31/03/2025

  • Employees paid over £60,000: 1 (£70,001–£80,000: 1)

Self-declared on the annual return for the financial year ending 31/03/2024

  • Volunteers: 1
  • Employees paid over £60,000: 1 (£70,001–£80,000: 1)

Self-declared on the annual return for the financial year ending 31/03/2023

  • Volunteers: 2
  • Employees paid over £60,000: 1 (£60,001–£70,000: 1)
  • Grant-making is its main activity

Source: this charity’s annual returns on the Charity Commission register.

Annual return filing dates (Charity Commission record)

Of its last 5 annual returns with a recorded received date, 1 was received after the due date: year ending 31/03/2023 (received 14/05/2024, 104 days after the 31/01/2024 due date).

Due and received dates as recorded in the Commission’s annual-return data; the data does not say whether an extension was agreed. Source: this charity’s annual returns on the Charity Commission register.

Public fundraising profile: JustGiving — The Institute for Cancer Vaccines and Immunotherapy (matched by registered charity number).

Structured financials (annual return, FY ending 31/03/2023)

Total income
£621k
Total spending
£585k
Cost of raising funds
£81k
Reserves (reported)
£1.4m
Employees
2

Reported reserves equal ~29.4 months of spending — in the top quarter for charities its size (median 7.2 months; benchmarks).

Per its annual return, largest income source: Donations and legacies (97% of income) — components as reported reconcile to the return’s total income; not from the accounts narrative.

Per its annual return, cost of raising funds: 13.1% of total income — in the top quarter for charities its size (median 3.2%) (benchmarks).

Register events

Trustees · trustee networks

Trustee list from the Charity Commission register (current, not historical).

Operates in: Throughout England And Wales

Income and spending

Financial year endIncomeSpending
31/03/2025£433k£547k
31/03/2024£261k£578k
31/03/2023£621k£585k
31/03/2022£566k£744k
31/03/2021£685k£794k

Common questions

Is THE INSTITUTE FOR CANCER VACCINES AND IMMUNOTHERAPY financially healthy?

Per its FY2025 accounts: The accounts state that the charity reported a net deficit of £122,083 for the year ended 31 March 2025, resulting in a decrease in total net assets to £993,795. Per the trustees' report, unrestricted reserves stood at £852,749, which the trustees consider sufficient to cover committed operating costs and provide flexibility for temporary shortfalls in fundraising revenues. The charity maintains its reserves in cash or cash equivalents to maintain short-term capital value amid market uncertainties. Its FY2025 accounts were audited by Bryden Johnson Limited.

What does the highest-paid employee of THE INSTITUTE FOR CANCER VACCINES AND IMMUNOTHERAPY earn?

Per its FY2025 accounts, the highest-paid employee was in the £70,001 - £80,000 band, and 1 employees earned over £60,000.

Who funds THE INSTITUTE FOR CANCER VACCINES AND IMMUNOTHERAPY?

Funders whose own accounts filings name THE INSTITUTE FOR CANCER VACCINES AND IMMUNOTHERAPY as a grant recipient include THE MASTER CHARITABLE TRUST, THE BILLMEIR CHARITABLE TRUST, THE ADRIAN SWIRE CHARITABLE TRUST, THE BELLASIS TRUST, THE PHILIP OPPENHEIMER FOUNDATION.

Known funders

Grants to this charity found in funders’ own accounts filings.

Grants marked “Unverified read” were flagged by automated checks as possibly misread from the funder’s filed accounts. They are listed, but left out of the totals, counts and funder relationships this site computes.

Funders of similar charities

Funders whose accounts show grants to charities similar to this one (and no recorded grant to this charity) — a starting list for fundraisers.

Charities like this

Semantically similar by activities and financial character, from our analysed corpus. Compare with INTERNATIONAL CANCER IMAGING SOCIETY.

Side by side with its peers

CharityIncomeTop pay bandStaff >£60kReserves vs policyFundraising costGoing concern
THE INSTITUTE FOR CANCER VACCINES AND IMMUNOTHERAPY£433k£70,001 - £80,0001unclear6.0%no doubt
INTERNATIONAL CANCER IMAGING SOCIETY FY2025£186k—0unclear—no doubt
CANCER AWARENESS TRUST FY2024£1.1m£100,001 - £110,000—unclear—no doubt
COMBAT CANCER FY2025£50k—0above—no doubt
FIGHTING ALL CANCERS TOGETHER FY2025£554k—0below—no doubt
THE NUCLEAR INSTITUTE FY2025£1.4m——above—no doubt

Each row is that charity’s latest analysed filing; every value is quote-backed on its own page.